Counterclaim FACTS RELEVANT TO COUNTERCLAIMS 84.

New Post Public Reply Private Reply Replies (1) Message Board
Coujoe62
Counterclaim


FACTS RELEVANT TO COUNTERCLAIMS
84. Plaintiff developed a scheme whereby it preys upon publicly trading companies in
desperate need of operating capital and makes usurious loans convertible into common stock .
85. Plaintiff set up its “loan arrangements” with defendant with the intent to convert the
defendant’s debt into publicly trading stock at a usurious rate of interest.
86. Plaintiff assured defendant that it would not convert defendants’ stock and would, rather,
work with defendant to avoid enforcing the illegal usurious terms of the agreement.
87. As a result of the subject loan agreement, plaintiff is attempting to usurp common trading
stock from the defendant and then, effectively, dump it into the market and drive the
price of defendant’s stock into near oblivion while enjoying substantial profit.
88. The Plaintiff knowingly, intentionally and willfully advanced sums to the Defendants
which it was aware could not be repaid.
89. The Plaintiff knowingly, intentionally and willfully advanced such sums to the
Defendants upon oppressive, usurious, improper, unlawful and unfair terms.
90. The Plaintiff knowingly, intentionally and willfully advanced such sums to the
Defendants with the understanding that they were under extreme economic duress and would
accede to any terms that the Plaintiff dictated.
91. The Plaintiff knowingly, intentionally and willfully advanced such sums with the
Case 2:15-cv-07254-SJF-GRB Document 14 Filed 01/26/16 Page 13 of 18 PageID #: 51
understanding that it would receive trading common stock well in excess of the value of the
purported loans so that it could then engage in illicit and detrimental trading of such stock, all
to its own benefit and all to the detriment of the Defendants.
FIRST COUNTERCLAIM
92. FRAUDULENT MISREPRESENTATION
a)Plaintiffs made aforesaid representation to defendants concerning the loan and the agreement,
and the Plaintiff and its affiliates such that
b)said representations were false;
c)that when made, the representations were known to be false or made recklessly without
knowledge of its truth;
d)that said representations were made with the intention that the defendants rely on them;
e)that the defendants did rely on them; and
f)that the defendants suffered damages as a result thereof.
SECOND COUNTERCLAIM
93. VIOLATION OF NY PENAL LAW §190.40 (CRIMINAL USURY)
a)that the costs of plaintiffs loans bore interest in excess of 150%
b)that said interest rate exceeds the maximum rate allowable in New York State
c)that Defendants are damaged as a result thereof
Case 2:15-cv-07254-SJF-GRB Document 14 Filed 01/26/16 Page 14 of 18 PageID #: 52
THIRD COUNTERCLAIM
94. FRAUDULENT INDUCEMENT
a)that Plaintiffs made knowing misrepresentation of material facts relating to loans made to
defendants;
b)that Plaintiffs had intention to deceive defendants;
c)that defendants relied on said misrepresentations; and
d)defendants suffered injury therefrom
FOURTH COUNTERCLAIM
95. TORTIOUS INTERFERENCE
a)Plaintiff caused Defendants to retain auditors, brokers, accountants; and
b)Plaintiff required Defendants to pay said professionals fees and costs
c)that Plaintiff’s aforesaid agents caused damages to defendants.
FIFTH COUNTERCLAIM
96. FRAUD
a)that Plaintiff made representation of fact relating to Plaintiffs loan, contracts, and affiliates;
b)that Plaintiff’s representations were false;
c)that said representations were material;
d)Plaintiffs knew of the representations falsity, or were ignorant of the truth;
e)the Plaintiffs had intent that said representations should be acted upon by the defendants in the
manner reasonably contemplated;
Case 2:15-cv-07254-SJF-GRB Document 14 Filed 01/26/16 Page 15 of 18 PageID #: 53
f)that defendants, the injured parties, were ignorant of the falsity of said representations;
g)that defendants relied on the truth of said representations;
h)that defendants had the right to rely thereon; and
I) that said false representations caused consequent and proximate injury to defendants.
SIXTH COUNTERCLAIM
97. RESCISSION
Equity requires that defendants’ transactions with Plaintiffs should be rescinded because it was
consummated through material misrepresentations as set forth above, even if fraud has been
alleged but the facts do not rise to the level of actionable fraud:
SEVENTH COUNTERCLAIM
98. PRIMA FACIE TORT
a) Plaintiffs intended to damage corporate driving price down, and depriving individual
defendant of profit
b)Plaintiffs had intent to cause ill will or knew their acts would damage defendants
c)Plaintiffs acts caused Damage to Corporate Defendant’s Business or Trade
d)Plaintiffs acts not justifiable under circumstances
EIGHTH COUNTERCLAIM
99. NY GBL § 349
a)Plaintiff’s acts or practices were deceptive business practices directed at consumer-oriented
Case 2:15-cv-07254-SJF-GRB Document 14 Filed 01/26/16 Page 16 of 18 PageID #: 54
borrower Defendants;
b)said acts or practices were misleading in a material respect; and
c)the defendants were injured as a result of the deceptive act or practice.
WHEREFORE, Defendants respectfully request that plaintiffs’ complaint be denied in its
entirety, and, that this Honorable Court enters judgment in favor of defendants on their
Counterclaims awarding :actual damages upon proof at trial ; as well as:
- Treble damages;
- Injunctive relief;
- Disgorgement of profits;
- Punitive damages;
-Reasonable attorney fees and costs of litigation; and such other and further relief as to this court
seems just and proper.
Dated: January 24, 2016
Brooklyn, New York Yours, etc., /S/ RY6560
Robert Young, Esq.
Ellsworth, Young, LLP
1164 Manhattan Avenue
Brooklyn, NY 11222
718-875-8000
Rjy24@aol.com
Case 2:15-cv-07254-SJF-GRB Document 14 Filed 01/26/16 Page 17 of 18 PageID #: 55
Case 2:15-cv-07254-SJF-GRB Document 14 Filed 01/26/16 Page 18 of 18 PageID #: 56

Hangover Joe's Holding Corporation (HJOE) Stock Research Links

HJOE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 0

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 141

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Hyundai’s Third SUV Crown Matters Beyond the Trophy

Updated Category News Views 0

A Three-Year Streak Is Not Just Decorative Three straight SUV-brand wins can make even a cynical car watcher pause. Hyundai has been named U.S. News & World Report’s 2027 Best SUV Brand after editors assessed vehicles from 39 brands, and that is a useful bit of outside validation in a segment where nearly everybody is throwing sheet metal, screens, and marketing dollars...

Continue Reading
NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 79

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 131

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 151

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 30

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead

Updated Category News Views 24

A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 190

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading

Top 5 Most Recently Viewed Articles

DallasNews Shareholders Urged to Support Merger Deal with Hearst

Updated Category News Views 101

Overview of the DallasNews and Hearst Merger DallasNews Corporation, the parent company of The Dallas Morning News, has proposed a significant merger with Hearst, a prominent media organization. This merger offers an enticing cash value of $15.00 per share, bringing impressive benefits to shareholders. Recently, Glass Lewis, an independent proxy advisory firm, recommended...

Continue Reading
GitLab Director Karen Blasing's Recent Stock Transactions Explained

Updated Category News Views 154

Analyzing the Recent Insider Trading at GitLab GitLab Inc. (NASDAQ:GTLB) has recently drawn the attention of investors and market analysts due to stock transactions made by its director, Karen Blasing. A recent filing with the U.S. Securities and Exchange Commission revealed that Blasing sold a considerable amount of her stock holdings, totaling more than $173,000....

Continue Reading
Avenue Living's Strategic $350 Million Debenture Offering

Updated Category News Views 202

Avenue Living Announces $350 Million Senior Unsecured Debenture Offering Avenue Living (2014) LP has recently announced a significant financial move with a $350 million offering of Series B senior unsecured debentures. This opportunity is set to be priced at par and is due by September 25, 2028, indicating a long-term strategy for the company’s financing needs. Details...

Continue Reading
Fagron Reports Strong Financial Growth with Strategic Outlook

Updated Category News Views 349

Fagron's Remarkable Financial Performance Fagron, a global leader in pharmaceutical compounding, recently showcased its impressive results for the period ending December 31, 2024. The company’s financial achievements highlight significant growth across various sectors and regions in the pharmaceutical industry, reinforcing its commitment to excellence and innovation....

Continue Reading
Dizal's Sunvozertinib Receives Breakthrough Therapy Designation

Updated Category News Views 444

Dizal's Sunvozertinib Achieves Breakthrough Therapy Designation Dizal, a biopharmaceutical company dedicated to developing innovative cancer and immunological therapies, recently announced an important milestone. The Center for Drug Evaluation of China's National Medical Products Administration has granted Breakthrough Therapy Designation for sunvozertinib, aimed at...

Continue Reading